Former FDA Commish Califf Advocates Cosmetics Registration, AE Reporting
This article was originally published in The Rose Sheet
Executive Summary
FDA is hampered in its public safety mission under current law, which does not require cosmetics firms to register marketed products or report adverse events, former agency head Robert Califf says. His June 26 editorial in Jama Internal Medicine accompanies an analysis of FDA's cosmetics adverse-event data.
You may also be interested in...
Gottlieb Unlikely To Make Major Changes Right Away, Former Official Says
New US FDA commissioners have a lot of housekeeping to do before they can get to the fun stuff, according to former associate commissioner Wayne Pines.
Think FDA Inspections Are Painful Now? These Could Be The Good Old Days
ICMAD's recent regulatory workshop offered perspective from FDA's Linda Katz and industry experts on the inspection process for cosmetics facilities under current law. It's clear that FDA inspections can be an ordeal, but that would pale in comparison to challenges that could arise under the proposed Personal Care Products Safety Act.
PCPSA Recast Offers Small-Biz Concessions, Gains New Industry Support
The recast of the Personal Care Products Safety Act includes new exemptions and revised fee expectations for the smallest cosmetics businesses, winning support from their trade groups. But the Independent Cosmetic Manufacturers and Distributors, whose members range in size up to Mary Kay, still finds the bill's proposed regulatory framework too burdensome to get behind.